We are live on ! Find out more
FIM

Fernwood Investment Management Portfolio holdings

AUM $288M
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+8.46%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$242M
AUM Growth
+$4.67M
Cap. Flow
-$8.98M
Cap. Flow %
-3.72%
Top 10 Hldgs %
29.52%
Holding
191
New
6
Increased
46
Reduced
60
Closed
9

Top Buys

Rank Stock Value
1
PLRX icon
Pliant Therapeutics
PLRX
+$1.71M
2
CISO
CISO Global
CISO
+$1.18M
3
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$610K
4
DGRO icon
iShares Core Dividend Growth ETF
DGRO
+$488K
5
NVDA icon
NVIDIA
NVDA
+$444K

Top Sells

Rank Stock Value
1
GBT
Global Blood Therapeutics, Inc.
GBT
+$11.9M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$374K
3
TIP icon
iShares TIPS Bond ETF
TIP
+$274K
4
SRLN icon
State Street Blackstone Senior Loan ETF
SRLN
+$253K
5
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$226K

Sector Composition

Rank Sector Weight
1 Healthcare 17.82%
2 Technology 11.47%
3 Energy 11.25%
4 Financials 7.65%
5 Consumer Discretionary 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VVR icon
176
Invesco Senior Income Trust
VVR
$457M
$65.7K 0.03%
17,143
-892
-5% -$3.4K
CGNT icon
177
Cognyte Software
CGNT
$675M
$65.2K 0.03%
20,950
-2,000
-9% -$5.87K
JNCE
178
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$35.8K 0.01%
32,259
– –
DHF
179
BNY Mellon High Yield Strategies Fund
DHF
$175M
$35.4K 0.01%
16,400
– –
QVCGA
180
DELISTED
QVC Group Inc Series A
QVCGA
$32.6K 0.01%
400
– –
LX
181
LexinFintech Holdings
LX
$237M
$21.9K 0.01%
11,500
– –
AWH
182
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$3.33K ﹤0.01%
667
– –
AMLP icon
183
Alerian MLP ETF
AMLP
$13.2B
– –
-5,941
Closed -$217K
EEM icon
184
iShares MSCI Emerging Markets ETF
EEM
$30.4B
– –
-6,476
Closed -$226K
EFA icon
185
iShares MSCI EAFE ETF
EFA
$80.2B
– –
-6,684
Closed -$374K
PTON icon
186
Peloton Interactive
PTON
$2.38B
– –
-29,115
Closed -$202K
SRLN icon
187
State Street Blackstone Senior Loan ETF
SRLN
$5.37B
– –
-6,191
Closed -$253K
TIP icon
188
iShares TIPS Bond ETF
TIP
$14.7B
– –
-2,612
Closed -$274K
TWLO icon
189
Twilio
TWLO
$37.9B
– –
-3,160
Closed -$218K
ZTS icon
190
Zoetis
ZTS
$30.4B
– –
-1,352
Closed -$200K
GBT
191
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-174,724
Closed -$11.9M
4 5 6 7
8

Similar funds

CIM
Chiron Investment Management New York $300M AUM 49.09% 1-Year Est. Return
CSWM
Cassady Schiller Wealth Management Cincinnati, Ohio $273M AUM 17.91% 1-Year Est. Return
WWP
WR Wealth Planners Columbia, Missouri $311M AUM 18.22% 1-Year Est. Return
GWM
Gray Wealth Management Bangor, Maine $264M AUM 19.5% 1-Year Est. Return
FWM
Fairhaven Wealth Management Oak Brook, Illinois $320M AUM 17.7% 1-Year Est. Return
MWS
Maxwell Wealth Strategies Pleasanton, California $245M AUM 23.39% 1-Year Est. Return
AP
Agilis Partners Waltham, Massachusetts $332M AUM 10.57% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Fernwood Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Fernwood Investment Management held 191 positions worth $242M, up 2% from $237M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Fernwood Investment Management withdrew a net $8.98M in Q4 2022, closing 9 positions and reducing 60 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Technology and Energy.

Against the trend, Fernwood Investment Management opened a new position in Revolution Medicines worth $336K.

  • Fernwood Investment Management's largest Q4 2022 buy was Revolution Medicines: 14,125 shares worth $336K.
  • Fernwood Investment Management added most to Pliant Therapeutics in Q4 2022, an estimated $1.71M increase.
  • Fernwood Investment Management's biggest Q4 2022 reduction was Iridium Communications, cutting an estimated $213K.
  • Fernwood Investment Management fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $11.9M.
  • Fernwood Investment Management's ten largest holdings make up 30% of its $242M portfolio in Q4 2022.
  • Fernwood Investment Management opened 6 new positions and closed 9 in Q4 2022.
  • Fernwood Investment Management's portfolio value rose 2% quarter-over-quarter to $242M.

Based on Fernwood Investment Management's 13F filing for Q4 2022, filed 7 Feb 2023.